Report finds large state disparities in progress against colorectal cancer

Key points
- Progress in reducing colorectal cancer (CRC) mortality rates varies significantly across states, with rates in the Northeast showing the most progress and those in the South showing the least progress, according to a new study.
- Colorectal cancer mortality rates have been decreasing for many decades in the United States, with the decrease accelerating in the most recent time period.
- To investigate, researchers led by American Cancer Society epidemiologist Ahmedin Jemal, Ph.D., analyzed trends in age-standardized CRC death rates for each state from 1990-2007.
- The authors conclude that progress in CRC mortality varies across states, with the Northeast showing the most progress and the South showing the least progress, and that the findings highlight the need for wider dissemination of CRC screening.
Progress in reducing colorectal cancer (CRC) mortality rates varies significantly across states, with rates in the Northeast showing the most progress and those in the South showing the least progress, according to a new study. As a result, the highest burden of CRC mortality shifted from the Northeast in the early 1990s to the southern states along the Appalachian corridor in the mid 2000s. The decrease in CRC mortality rates by state correlated strongly with uptake of screening.
The study appears in Cancer Epidemiology Biomarkers and Prevention, and says improving screening rates through state-specific initiatives and/or expansion of the Colorectal Cancer Control Program of the Centers for Disease Control and Prevention to the Appalachian region and certain southern states could lessen the disproportionately high burden of CRC in these states.
Colorectal cancer mortality rates have been decreasing for many decades in the United States, with the decrease accelerating in the most recent time period. The extent to which this decrease varies across states and its influence on the geographic patterns of rates was previously unknown.
To investigate, researchers led by American Cancer Society epidemiologist Ahmedin Jemal, Ph.D., analyzed trends in age-standardized CRC death rates for each state from 1990-2007. They found CRC mortality rates significantly decreased in all states except Mississippi between 1990-2007 based on the joinpoint model. The decrease in death rates between 1990-1994 and 2003-2007 ranged from 9% in Alabama to >33% in Massachusetts, Rhode Island, New York, and Alaska. Mississippi and Wyoming showed no significant decrease. Generally, the northeastern states showed the largest decreases, while southern states showed the smallest decreases. The highest CRC mortality rates shifted from the northeastern states during 1990-1994 to the southern states along the Appalachian corridor during 2003-2007. The decrease in CRC mortality rates by state correlated strongly with uptake of screening.
The authors conclude that progress in CRC mortality varies across states, with the Northeast showing the most progress and the South showing the least progress, and that the findings highlight the need for wider dissemination of CRC screening.
###
Article: "State Disparities in Colorectal Cancer Mortality Patterns in the United States," D. Naishadham, I. Lansdorp-Vogelaar, R. Siegel, V. Cokkinides1, A. Jemal. Cancer Epidemiol Biomarkers Prev; 20(7); 1296–. doi: 10.1158/1055-9965.EPI-11-0250
###
Contact: David Sampson
[email protected]
American Cancer Society
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsSevere Form of "Enlarged Prostate" Disease Discovered
Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night. What they may not know is that the disease known as BPH (benign prostatic hyperplasia),…
7 February 2007
NewsAspirin, Other NSAIDs, May Prevent or Delay Enlarged Prostate
Mayo Clinic researchers have found that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may prevent or delay benign prostatic hyperplasia, an enlarged prostate which can cause urinary…
31 August 2006
NewsDutasteride useful for enlarged prostate
Dutasteride (also known as Avodart or Duprost) appears to have a variety of beneficial effects in treating benign prostatic hyperplasia (BPH), French researchers report. BPH, an enlargement of the prostate gland, is a…


